Early Effects of Combretastatin A4 Phosphate Assessed by Anatomic and Carbogen-Based Functional Magnetic Resonance Imaging on Rat Bladder Tumors Implanted in Nude Mice

Combretastatin A4 phosphate (CA4P) causes rapid disruption of the tumor vasculature and is currently being evaluated for antivascular therapy. We describe the initial results obtained with a noninvasive multiparametric magnetic resonance imaging (MRI) approach to assess the early effects of CA4P on...

Full description

Bibliographic Details
Main Authors: Carole D. Thomas, Christine Walczak, Julia Kaffy, Renée Pontikis, Jacqueline Jouanneau, Andreas Volk
Format: Article
Language:English
Published: Elsevier 2006-07-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S147655860680014X
_version_ 1811264590391017472
author Carole D. Thomas
Christine Walczak
Julia Kaffy
Renée Pontikis
Jacqueline Jouanneau
Andreas Volk
author_facet Carole D. Thomas
Christine Walczak
Julia Kaffy
Renée Pontikis
Jacqueline Jouanneau
Andreas Volk
author_sort Carole D. Thomas
collection DOAJ
description Combretastatin A4 phosphate (CA4P) causes rapid disruption of the tumor vasculature and is currently being evaluated for antivascular therapy. We describe the initial results obtained with a noninvasive multiparametric magnetic resonance imaging (MRI) approach to assess the early effects of CA4P on rat bladder tumors implanted on nude mice. MRI (4.7 T) comprised a fast spin-echo sequence for growth curve assessment; a multislice multiecho sequence for T2 measurement before, 15 minutes after, 24 hours after CA4P (100 mg/kg); and a fast T2W* gradient-echo sequence to assess MR signal modification under carbogen breathing before, 35 minutes after, 24 hours after CA4P. The tumor fraction with increased T2W* signal intensity under carbogen (T+) was used to quantify CA4P effect on functional vasculature. CA4P slowed tumor growth over 24 hours and accelerated necrosis development. T+ decrease was observed already at 35 minutes post-CA4P. Early T2 increase was observed in regions becoming necrotic at 24 hours post-CA4P, as confirmed by high T2 and histology. These regions exhibited, under carbogen, a switch from T2W* signal increase before CA4P to a decrease postCA4P. The combination of carbogen-based functional MRI and T2 measurement may be useful for the early follow-up of antivascular therapy without the administration of contrast agents.
first_indexed 2024-04-12T20:07:06Z
format Article
id doaj.art-81fc26b475674f6fb029de9307a4c53f
institution Directory Open Access Journal
issn 1476-5586
1522-8002
language English
last_indexed 2024-04-12T20:07:06Z
publishDate 2006-07-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj.art-81fc26b475674f6fb029de9307a4c53f2022-12-22T03:18:22ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022006-07-018758759510.1593/neo.06232Early Effects of Combretastatin A4 Phosphate Assessed by Anatomic and Carbogen-Based Functional Magnetic Resonance Imaging on Rat Bladder Tumors Implanted in Nude MiceCarole D. Thomas0Christine Walczak1Julia Kaffy2Renée Pontikis3Jacqueline Jouanneau4Andreas Volk5INSERM, U759, Orsay F-91405, FranceINSERM, U759, Orsay F-91405, FranceCNRS, UMR 176, Paris F-75005, FranceCNRS, UMR 176, Paris F-75005, FranceInstitut Curie Research Center, Paris F-75005, FranceINSERM, U759, Orsay F-91405, FranceCombretastatin A4 phosphate (CA4P) causes rapid disruption of the tumor vasculature and is currently being evaluated for antivascular therapy. We describe the initial results obtained with a noninvasive multiparametric magnetic resonance imaging (MRI) approach to assess the early effects of CA4P on rat bladder tumors implanted on nude mice. MRI (4.7 T) comprised a fast spin-echo sequence for growth curve assessment; a multislice multiecho sequence for T2 measurement before, 15 minutes after, 24 hours after CA4P (100 mg/kg); and a fast T2W* gradient-echo sequence to assess MR signal modification under carbogen breathing before, 35 minutes after, 24 hours after CA4P. The tumor fraction with increased T2W* signal intensity under carbogen (T+) was used to quantify CA4P effect on functional vasculature. CA4P slowed tumor growth over 24 hours and accelerated necrosis development. T+ decrease was observed already at 35 minutes post-CA4P. Early T2 increase was observed in regions becoming necrotic at 24 hours post-CA4P, as confirmed by high T2 and histology. These regions exhibited, under carbogen, a switch from T2W* signal increase before CA4P to a decrease postCA4P. The combination of carbogen-based functional MRI and T2 measurement may be useful for the early follow-up of antivascular therapy without the administration of contrast agents.http://www.sciencedirect.com/science/article/pii/S147655860680014XRat bladder tumorsmousecarbogenfMRIantivascular therapy
spellingShingle Carole D. Thomas
Christine Walczak
Julia Kaffy
Renée Pontikis
Jacqueline Jouanneau
Andreas Volk
Early Effects of Combretastatin A4 Phosphate Assessed by Anatomic and Carbogen-Based Functional Magnetic Resonance Imaging on Rat Bladder Tumors Implanted in Nude Mice
Neoplasia: An International Journal for Oncology Research
Rat bladder tumors
mouse
carbogen
fMRI
antivascular therapy
title Early Effects of Combretastatin A4 Phosphate Assessed by Anatomic and Carbogen-Based Functional Magnetic Resonance Imaging on Rat Bladder Tumors Implanted in Nude Mice
title_full Early Effects of Combretastatin A4 Phosphate Assessed by Anatomic and Carbogen-Based Functional Magnetic Resonance Imaging on Rat Bladder Tumors Implanted in Nude Mice
title_fullStr Early Effects of Combretastatin A4 Phosphate Assessed by Anatomic and Carbogen-Based Functional Magnetic Resonance Imaging on Rat Bladder Tumors Implanted in Nude Mice
title_full_unstemmed Early Effects of Combretastatin A4 Phosphate Assessed by Anatomic and Carbogen-Based Functional Magnetic Resonance Imaging on Rat Bladder Tumors Implanted in Nude Mice
title_short Early Effects of Combretastatin A4 Phosphate Assessed by Anatomic and Carbogen-Based Functional Magnetic Resonance Imaging on Rat Bladder Tumors Implanted in Nude Mice
title_sort early effects of combretastatin a4 phosphate assessed by anatomic and carbogen based functional magnetic resonance imaging on rat bladder tumors implanted in nude mice
topic Rat bladder tumors
mouse
carbogen
fMRI
antivascular therapy
url http://www.sciencedirect.com/science/article/pii/S147655860680014X
work_keys_str_mv AT caroledthomas earlyeffectsofcombretastatina4phosphateassessedbyanatomicandcarbogenbasedfunctionalmagneticresonanceimagingonratbladdertumorsimplantedinnudemice
AT christinewalczak earlyeffectsofcombretastatina4phosphateassessedbyanatomicandcarbogenbasedfunctionalmagneticresonanceimagingonratbladdertumorsimplantedinnudemice
AT juliakaffy earlyeffectsofcombretastatina4phosphateassessedbyanatomicandcarbogenbasedfunctionalmagneticresonanceimagingonratbladdertumorsimplantedinnudemice
AT reneepontikis earlyeffectsofcombretastatina4phosphateassessedbyanatomicandcarbogenbasedfunctionalmagneticresonanceimagingonratbladdertumorsimplantedinnudemice
AT jacquelinejouanneau earlyeffectsofcombretastatina4phosphateassessedbyanatomicandcarbogenbasedfunctionalmagneticresonanceimagingonratbladdertumorsimplantedinnudemice
AT andreasvolk earlyeffectsofcombretastatina4phosphateassessedbyanatomicandcarbogenbasedfunctionalmagneticresonanceimagingonratbladdertumorsimplantedinnudemice